Robert Iannone
Chief Tech/Sci/R&D Officer bei JAZZ PHARMACEUTICALS PLC
Vermögen: 7 Mio $ am 31.03.2024
Profil
Dr. Robert Iannone, MD, ist ein unabhängiger Direktor bei iTeos Therapeutics, Inc. und ein unabhängiger Direktor bei Jounce Therapeutics, Inc. sowie Chief Medical Officer, EVP-Research & Development bei Jazz Pharmaceuticals Plc. Er ist Mitglied des Board of Directors bei iTeos Therapeutics, Inc. und Jounce Therapeutics, Inc. Dr. Iannone war zuvor als Chief Medical Officer, Head-Research & Development bei Immunomedics, Inc. beschäftigt, als SVP, Head-Immuno-Oncology & Global Medicines bei AstraZeneca Plc, als Executive Director & Head-Oncology bei Merck & Co, Inc. und als Adjunct Assistant Professor am University of Pennsylvania Medical Center. Er erhielt seinen Bachelor-Abschluss von der Katholischen Universität von Amerika, einen Master-Abschluss von der University of Pennsylvania Medical Center und einen Doktortitel von der Yale School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.03.2024 | 62 226 ( 0,10% ) | 7 Mio $ | 31.03.2024 | |
ITEOS THERAPEUTICS, INC.
-.--% | 13.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Robert Iannone
| Unternehmen | Position | Beginn |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 29.05.2019 |
| ITEOS THERAPEUTICS, INC. | Director/Board Member | 03.05.2021 |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 20.06.2023 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | 01.05.2019 |
Ehemalige bekannte Positionen von Robert Iannone
| Unternehmen | Position | Ende |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Director/Board Member | 03.05.2023 |
| IMMUNOMEDICS, INC. | Chief Tech/Sci/R&D Officer | 28.05.2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.04.2018 |
| MERCK & CO., INC. | Director/Board Member | 01.07.2014 |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Robert Iannone
| The Catholic University of America | Undergraduate Degree |
| Yale University | Doctorate Degree |
| University of Pennsylvania Medical Center | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
